Related Experiment Video
Updated: Dec 14, 2025
Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro
Published on: March 18, 2014
Unveiling dose- and time-dependent osteosarcoma cell responses to the γ-secretase inhibitor, DAPT, by confocal Raman
Jie Li1, Jie Qin2, Haishan Zeng3
1Institute of Photonics and Photon-Technology, Northwest University, Xi'an, Shaanxi, China.
Abstract:
Using confocal Raman micro-spectroscopy, this study aims to elucidate the cellular responses of the γ-secretase inhibitor, N-[N-(3,5-difluorophenacetyl)-L-alanyl]-S-phenylglycine t-butyl ester (DAPT), in osteosarcoma (OS) cells in a dose- and time-dependent manner. The K7M2 murine OS cell line was treated with different DAPT doses (0, 10, 20, and 40 μM) for 24 and 48 hours before investigations. Significant compositional changes (nucleic acids, protein and lipid) after DAPT treatment were addressed, which testified inhibitory effect of DAPT on the growth of OS cells. Moreover, both partial least squares-discriminant analysis (PLS-DA) and principal component analysis-linear discriminant analysis (PCA-LDA) analyses revealed governing composition variations among groups by distinguishing their spectral characteristics. Furthermore, by adopting leave-one-out cross validation method, it is shown that PLS-DA exhibited more classification capacity than PCA-LDA algorithm. Hence, by understanding the DAPT-based cellular variations, the achieved results provided an experimental foundation to establish new DAPT-based anticancer therapeutic strategies, and preclinical Raman analytical methodologies on drug-cell interactions.
Insights
This study reveals how the γ-secretase inhibitor DAPT affects osteosarcoma cells. Raman spectroscopy identified significant cellular changes, demonstrating DAPT
Area of Science:
- Biochemistry
- Cell Biology
- Spectroscopy
Background:
- Osteosarcoma (OS) is a primary bone cancer.
- γ-secretase inhibitors, like DAPT, are investigated for cancer therapy.
- Understanding drug-cell interactions is crucial for developing new treatments.
Purpose of the Study:
- To investigate the cellular responses of osteosarcoma cells to the γ-secretase inhibitor DAPT.
- To analyze dose- and time-dependent effects of DAPT on K7M2 murine OS cells.
- To establish Raman spectroscopy as a tool for monitoring drug-cell interactions in cancer research.
Main Methods:
- Confocal Raman micro-spectroscopy was employed to analyze cellular composition.
- K7M2 murine OS cells were treated with varying DAPT concentrations (0-40 μM) over 24 and 48 hours.
- Multivariate statistical analyses, including PLS-DA and PCA-LDA, were used to interpret spectral data.
Main Results:
- DAPT treatment induced significant changes in nucleic acid, protein, and lipid content in OS cells.
- These compositional alterations indicate an inhibitory effect of DAPT on OS cell growth.
- PLS-DA demonstrated superior classification capacity compared to PCA-LDA in distinguishing spectral profiles.
Conclusions:
- The study provides a foundation for developing novel DAPT-based anticancer strategies.
- Raman spectroscopy effectively characterizes drug-induced cellular variations.
- This work highlights potential preclinical Raman analytical methodologies for drug-cell interaction studies.
